Phase I and pharimacokinetic trial of a novel inhibitor of NAD biosynthesis in patients with solid tumors.

被引：0

作者：

Holen, KD

Bolling, C

Saltz, LB

Graefe, T

Ty, V

Sogo, N

Starkmann, H

Burk, KH

Hollywood, E

Hanauske, AR

机构：

[1] St Georg Hosp, Hamburg, Germany

[2] Univ Wisconsin, Madison, WI USA

[3] MSKCC, New York, NY USA

[4] Fujisawa Pharmaceut Co Ltd, Osaka, Japan

[5] Fujisawa Deutschland GmbH, Munich, Germany

[6] ClinDesci GmbH, Munich, Germany

来源：

CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：6158S / 6158S

页数：1

共 50 条

[31] First in human phase I trial of the PARP inhibitor AG-014699 with temozolomide (TMZ) in patients (pts) with advanced solid tumors.
Plummer, R
Middleton, M
Wilson, R
Jones, C
Evans, J
Robson, L
Steinfeldt, H
Kaufman, R
Reich, S
Calvert, AH
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 208S - 208S
[32] Phase I trial of oxaliplatin and doxorubicin in children and adolescents with recurrent solid tumors.
Mascarenhas, L.
Armenian, S.
Harrington, J. L.
Mahmoud, H.
Sposto, R.
Malogolowkin, M. H.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[33] Phase I trial of pulse-dose vorinostat with flavopiridol in solid tumors.
Dickson, M. A.
Rathkopf, D. E.
Grant, S.
Roberts, J. D.
Reid, J. M.
Ames, M. M.
McGovern, R. M.
Gonen, M.
Dials, H. J.
Schwartz, G. K.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[34] Phase I trial of the combination of bortezomib and clofarabine in adults with refractory solid tumors.
Coyne, Geraldine Helen O'Sullivan
Kummar, Shivaani
Khanh Tu Do
Holbeck, Susan
Hollingshead, Melinda G.
Horneffer, Yvonne
Juwara, Lamin
Srivastava, Apurva K.
Rubinstein, Larry
Piekarz, Richard
Sharon, Elad
Streicher, Howard
Conley, Barbara A.
Antony, Ramya
Collins, Jerry M.
Chen, Alice
Doroshow, James H.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[35] A phase I study of ixabepilone combined with dasatinib in patients with solid tumors.
Kaiser, C. C.
Perry, D. J.
Zimmer, A. S.
Patterson, J. W.
Swain, S. M.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[36] Phase I study of sapacitabine and seliciclib in patients with advanced solid tumors.
Tolaney, Sara M.
Hilton, John Frederick
Cleary, James M.
Gandhi, Leena
Kwak, Eunice Lee
Clark, Jeffrey W.
Wolanski, Andrew
Bell, Tracy Demeo
Rodig, Scott J.
Chiao, Judy H.
Blake, David
Shapiro, Geoffrey
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[37] A phase I QTc study of tivozanib in patients with advanced solid tumors.
Chadha, Manpreet Kaur
Infante, Jeffrey R.
Cotreau, Monette M.
Jacobson, Lindsey
Strahs, Andrew Louis
Slichenmyer, William
Vargo, Dennis
Moore, Kathleen N.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
[38] Phase I/II trial of vorinostat in combination with etoposide in pediatric patients with relapsed/refractory solid tumors.
Trippett, Tanya M.
Smith, Amy
Neville, Kathleen
Chi, Susan
Narendran, Aru
Arceci, Robert
Direnzo, Jennifer
Gore, Lia
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
[39] Phase I clinical trial of temozolomide and methoxyamine (TRC-102) in patients with advanced solid tumors.
Eads, Jennifer Rachel
Krishnamurthi, Smitha S.
Saltzman, Joel N.
Meropol, Neal J.
Bokar, Joseph A.
Gibbons, Joseph
Koon, Henry B.
Sharma, Neelesh
Savvides, Panayiotis
Pink, John
Xu, Yan
Beumer, Jan Hendrik
Fu, Pingfu
Beatty, Kristi
Kane, Donna
Rodal, Mary Beth
Czalkiewicz, Julianne
Riendeau, John
Gerson, Stanton L.
Dowlati, Afshin
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[40] A phase I study of intravenous artesunate (IV AS) in patients with solid tumors.
Deeken, John F.
Wang, Hongkun
Smaglo, Brandon George
Hwang, Jimmy J.
He, Aiwu Ruth
Weiner, Louis M.
Marshall, John
Giaccone, Giuseppe
Liu, Stephen V.
Luecht, Jim
Urso, Christina
Spiegel, Jay Y.
Cheema, Amrita
Pishvaian, Michael J.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

← 1 2 3 4 5 →